Understand · Discuss · Plan together
Who Should Consider Genetic Testing?
Testing is most useful when the result can clarify care for the person or their family.
Chapter 7 of 16
Explore all 16 chapters
Reasons to discuss a clinical test
A known familial pathogenic variant, a suggestive personal or family history, or an abnormal tumour result can justify assessment. Certain cancer diagnoses merit testing consideration even without affected relatives, including epithelial ovarian cancer, pancreatic cancer, male breast cancer and metastatic prostate cancer. Eligibility in breast and colorectal cancer is broader than family history alone and should be checked with the treating team.
A practical decision guide
This educational guide does not diagnose inherited risk or recommend a test automatically. Choices are not saved or transmitted by the tool.
Choosing who to test first
When the familial cause is unknown, testing a relative who has had a relevant cancer is often more informative. If that person is unavailable or declines, an unaffected relative can still be assessed; counselling should explain why a negative result may not settle the family question. When a familial pathogenic variant is known, targeted testing may be appropriate.
Choosing the test
Ask what genes and variant types are covered, what the report will include and what actions each possible result would change. An ancestry test, a cancer-marker blood test and a germline cancer panel answer different questions. Repeating or expanding an older test can sometimes help, but is not automatically necessary.
Planning in India
Ask the hospital genetics or oncology service for a clinical laboratory with appropriate accreditation for the test. Confirm the total written cost, sample collection, turnaround, counselling, confirmatory testing and reclassification policy. Do not assume insurance coverage. If travel is difficult, ask whether a genetics consultation can be arranged remotely and how reports will be shared securely.
Sources and further reading
- NCI — Genetic Testing for Inherited Cancer Risk
- NCI PDQ — Cancer Genetics Risk Assessment and Counseling
Accessible sources checked: 19 October 2026. International recommendations are identified where used; care in India requires individual clinical assessment. No claim is made to have directly verified restricted NCCN guidance.